Dose Escalation Study Evaluating the Safety and Pharmacokinetics of VX-272 in Healthy Participants
Clinical trial NCT07437105 · RECRUITING
Trial details
- NCT number
- NCT07437105
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-25
- Primary completion
- 2027-03-23
- Enrollment
- 128
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.